Ochratoxin A: Molecular Interactions, Mechanisms of Toxicity and Prevention at the Molecular Level

Tamás Kőszegi1,2, Miklós Poór3

  • 1Department of Laboratory Medicine, University of Pécs, H-7624 Pécs, Hungary. tamas.koszegi@aok.pte.hu.

Toxins
|April 20, 2016
PubMed

Insights

Ochratoxin A (OTA) is a widespread mycotoxin posing health risks. This review details OTA

Area of Science:

  • Toxicology
  • Molecular Biology
  • Biochemistry

Background:

  • Ochratoxin A (OTA) is a prevalent mycotoxin globally, associated with significant health concerns.
  • Understanding the molecular and cellular mechanisms of OTA toxicity is crucial for risk assessment and mitigation.
  • The complex toxicological profile of OTA necessitates a comprehensive review of its interactions and effects.

Purpose of the Study:

  • To review the chemistry, toxicokinetics, and molecular/cellular interactions of Ochratoxin A.
  • To elucidate the complex mechanisms underlying OTA's toxicity.
  • To explore strategies for preventing or reducing OTA's toxic effects, focusing on OTA-albumin interactions.

Main Methods:

  • Literature review focusing on studies detailing Ochratoxin A's chemical properties and toxicokinetics.
  • Analysis of research on molecular and cellular pathways affected by OTA, including protein synthesis, energy production, oxidative stress, DNA damage, and cell death.
  • Detailed examination of OTA-albumin binding and the potential for displacement by therapeutic agents and natural compounds.

Main Results:

  • OTA exhibits complex toxicity involving multiple cellular targets and pathways.
  • Key mechanisms include inhibition of protein synthesis and energy production, oxidative stress induction, DNA adduct formation, and induction of apoptosis/necrosis and cell cycle arrest.
  • Strong binding of OTA to albumin is a significant factor in its toxicokinetics, with potential for displacement by other molecules.

Conclusions:

  • The toxicity of Ochratoxin A is multifaceted, involving intricate molecular and cellular interactions.
  • Further research into OTA-albumin binding and displacement offers potential therapeutic avenues for mitigating its adverse health effects.
  • Understanding these interactions is key to developing effective prevention and treatment strategies against OTA exposure.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.9K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.2K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
3.7K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
145
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
163
Indirect-Acting Cholinergic Agonists: Mechanism of Action01:18

Indirect-Acting Cholinergic Agonists: Mechanism of Action

Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
3.0K